Press release
Global Non-Hodgkin lymphoma treatment Market 2019 Growth, COVID Impact, Trends Analysis Report 2025
The global Non-Hodgkin lymphoma treatment market is anticipated to grow at a significant CAGR during the forecast period. The Non-Hodgkin lymphoma cancer is more common with high prevalence which will drive the Non-Hodgkin lymphoma treatment industry considerably. Non-Hodgkin lymphoma shows constitutional symptoms as well as hepatosplenomegaly symptoms. Constitutional symptoms include weight loss, hyperhidrosis, generalized hyperhidrosis, chronic pain, fatigue, and malaise. Whereas hepatosplenomegaly symptoms include abdominal pain, swelling or tenderness, nausea and vomiting, fever.To Request a Sample of our Report on Global Non-Hodgkin lymphoma treatment Market: https://www.omrglobal.com/request-sample/non-hodgkin-lymphoma-treatment-market
Some lymphomas will secrete Immunoglobulin M (IgM) which leads to hyperviscosity syndrome as well as autoimmune cytopenia. Hence, rise in autoimmune diseases across the globe will significantly drive the Non-Hodgkin lymphoma treatment market. The non-Hodgkin lymphomas also secrete gammaglobulinemia which leads to infectious diseases. Thus, the increasing infection will also drive the market.
Additionally, Non-Hodgkin lymphoma is the second most common cancer in patients with AIDS. According to the World Health Organization, 37.9 million people are living with HIV in 2018 across the globe. People living with HIV are about ten times more likely to develop Non-Hodgkin lymphoma than people without HIV. Hence the increasing AIDS cases across the globe is likely to drive the Non-Hodgkin lymphoma treatment market significantly.
Moreover, the risk of developing Non-Hodgkin lymphoma is significantly high after organ transplant as the patient’s immunity becomes weak after the transplantation. Therefore, the increase in organ transplantation activities will also fuel the Non-Hodgkin lymphoma treatment market. In addition to this, immunosuppressed as well as congenital immune deficiency patients are also at high risk of developing Non-Hodgkin lymphoma. Hence, the patient pool of these kind of diseases will significantly impact the Non-Hodgkin lymphoma treatment industry size.
Additionally, the increasing use of radiation and chemotherapy as the first line of treatment in lymphoma cancer will also impact the Non-Hodgkin lymphoma treatment market growth. Besides, the development and advancements of therapies such as CAR-T cells are also anticipated to drive the market during the forecast period.
(Get 15% Discount on Buying this Report)
A full Report of Global Non-Hodgkin lymphoma treatment Market is Available at: https://www.omrglobal.com/industry-reports/non-hodgkin-lymphoma-treatment-market
Global Non-Hodgkin Lymphoma Treatment Market- Segmentation
By Cell Type
• B-Cell
• T-Cell
By Therapy Type
• Chemotherapy
• Radiation
• Others
Global Non-Hodgkin Lymphoma Treatment Market- Segment by Region
North America
• US
• Canada
Europe
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe
Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific
Rest of the World
Company Profiles
• AbbVie Inc.
• Amgen Inc.
• AstraZeneca PLC
• Bayer AG
• Bristol Myers Squibb Co.
• Eli Lilly and Co.
• Epizyme, Inc.
• F. Hoffmann-La Roche Ltd.
• Gilead Sciences, Inc.
• GlaxoSmithKline PLC
• Johnson & Johnson Services Inc.
• Merck & Co., Inc.
• Nordic Nanovector ASA
• Novartis International AG
• Pfizer Inc.
• Sanofi SA
• Seattle Genetics, Inc.
• Sorrento Therapeutics, Inc.
• Spectrum Pharmaceuticals, Inc.
• Takeda Pharmaceutical Co. Ltd.
• Teva Pharmaceutical Industries Ltd.
Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/non-hodgkin-lymphoma-treatment-market
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Non-Hodgkin lymphoma treatment Market 2019 Growth, COVID Impact, Trends Analysis Report 2025 here
News-ID: 2238630 • Views: …
More Releases from Orion Market Research
Returnable Packaging Market Size 2023: Global Share, Industry And Report Analysi …
Returnable packaging market is anticipated to grow at a considerable CAGR of 6.5% during the forecast period (2024-2031). This type of packaging can include pallets, racks, bulk containers, hand-held containers, and dunnage. The market growth is driven by the growing demand and popularity of the returnable packaging, such as automotive, food and beverages, consumer durables and more. Also, the growth of e-commerceis supporting the market growth. Additionally disposable income and…
Phosphatidylcholine Market Size 2023: Global Share, Industry And Report Analysis …
Phosphatidylcholine market is anticipated to grow at a considerable CAGR of 6.1% during the forecast period (2024-2031). Phosphatidylcholine is a chemical contained in eggs, soybeans, mustard, sunflower, and other foods. It is found naturally in the body in all cells. Phosphatidylcholine is also a source of choline in the body. It is utilized in many different applications due to its offered benefits.
Get Free Sample link @ https://www.omrglobal.com/request-sample/Phosphatidylcholine…
Explosive Detection Technology Market Size 2023: Global Share, Industry And Repo …
Explosive detection technology market is anticipated to grow at a CAGR of 6.3% during the forecast period (2024-2031). The explosive detection technology market is driven by increasing security concerns, stringent regulations, technological advancements, increasing air passenger traffic, military modernization programs, investments in R&D, emerging new threats, integration of AI and ML, growing demand for non-intrusive screening solutions, and public safety concerns. These factors drive the adoption of explosive detection technologies…
Kidney Function Tests Market Size 2023: Global Share, Industry And Report Analys …
Kidney function tests market is anticipated to grow at a CAGR of 6.8% during the forecast period (2024-2031). Kidney function tests market is driven by the increasing prevalence of kidney diseases, such as chronic kidney disease, diabetic nephropathy, and glomerulonephritis, in addition to the diagnostic significance of these tests. Key players include diagnostic companies, laboratory equipment manufacturers, and healthcare institutions. Technological advancements, such as automation and molecular diagnostics, have improved…
More Releases for HIV
HIV-Associated Lipodystrophy Treatment Market - Increasing prevalence of HIV is …
HIV-associated lipodystrophy also known as lipodystrophy is a syndrome that occurs in HIV-infected patients. It is characterized by loss of subcutaneous fat from face, buttocks, arms and legs. Although the exact cause of HIV-associated lipodystrophy is not fully elucidated, some research evidence reported that it occurs in HIV-infected patients who are under antiretroviral medications. According to an article published in National Center for Biotechnology Information (NCBI) in 2014, prevalence of…
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication…
HIV Therapeutics Market– South Africa's Aspen launches three-in-one HIV drug
Recent Developments
Aspen Pharma care, a South Africa’s drug maker has launched a triple combination of tablet for the treatment of HIV in the country where the HIV virus is the most prevalent. The company's new Emdolten drug is a once a day tablet which is in the form of dolutegravir, an antiretroviral medication that balances the drug’s resistance. The company has launched Aspen Stavudine which was its first generic ARV…
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Introduction to Human Immunodeficiency Virus (HIV) Vaccines
1.1 Overview
1.2 Antiquity of HIV Vaccine
Need for the Development of HIV Vaccine
Primer of HIV inside the Body
3.1 Inclusion of HIV Virus into the System
3.2 Interaction of HIV with Host
3.3 Eradication of HIV Virus
HIV Vaccine Development Process
4.1 Introduction
…
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways…
Hidden HIV Revealed: New Insights Into Latent HIV Infections
In spite of ever more effective therapies, HIV keeps managing to survive in the body. A comprehensive project conducted by the Austrian Science Fund FWF has clarified the molecular processes which contribute to this effect. In the process, approaches were discovered for possible therapies to combat the hidden reservoir formed by the virus.
Thanks to modern therapies, HIV infections have become controllable – but these treatments cannot provide a cure. Antiretroviral…
